Coronary artery calcification, ADMA, and insulin resistance in CKD patients

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 5, 2008, Pages 1289-1295

  Kobayashi, Shuzo ^a   Oka, Machiko ^a   Maesato, Kyoko ^a   Ikee, Ryota ^a   Mano, Tsutomu ^a   Hidekazu, Moriya ^a   Ohtake, Takayasu ^a  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DRUG DERIVATIVE; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CALCINOSIS; CASE CONTROL STUDY; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; INSULIN RESISTANCE; KIDNEY DISEASE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK ASSESSMENT;

AGED; ARGININE; CALCINOSIS; CASE-CONTROL STUDIES; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN RESISTANCE; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 53749083322     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00010108     Document Type: Article

References (35)

1. Goodman GW, Goldin J, Kuizon DB, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000
2. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39: 695-701, 2002
3. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K: Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38: 64-69, 2001
4. Bursztyn M, Motro M, Grossman E, Shemesh J: Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation. J Hypertens 21:1953-1959, 2003
5. Russo D, Palmiero G, Blasio APD, Balletta MM, Andreucci VE: Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 44:1024-1030, 2004
6. Fox CS, Larson MG, Keyes MG, Levy D, Clouse ME, Culleton B, O'Donnell CJ: Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: the Framingham Study. Kidney Int 66: 2017-2021, 2004
7. Mehrotra R, Budoff M, Hokanson JE, Ipp E, Takasu J, Adler S: Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int 68: 1258-1266, 2005
8. McFarlane SI, Maryann A, Sowers JR: Insulin resistance and cardiovascular disease. J Clin Endcrinol Metab 86: 713-718, 2001
9. Chen J, Muntner P, Hamm LL, Fonscea V, Batuman V, Whelton PK: Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 14: 469-477, 2003
10. Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T: Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45: 275-280, 2004
11. Fadi A, El-Atat, Sameer N, Stas, Samy I, McFarlane, James R, Sowers JR: The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 15: 2816-2827, 2004
12. Arad Y, Newstein D, Cadet F, Roth M, Guerci AD: Association of multiple risk factors and insulin resistance with increased prevalence of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 21: 2051-2058, 2001
13. Stuhlinger MC, Abbasi MC, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS: Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287: 1420-1426, 2002
14. Boger RH, Bode-Borger SM, Szuba A, Philip ST, Chan JR, Oranee T, Terrence FB, Cooke JP: Asymmetric dimethylarginine: a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 98: 1842-1847, 1998
15. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP: Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99: 3092-3095, 1999
16. Cooke JP: Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20: 2032-2037, 2000
17. Kleinstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM, Frolich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10: 594-600, 1999
18. Meinitzer A, Seelhorst U, Wellnitz B, Halwachs-Baumann G, Boehm BO, Winkelmann BR, Matz W: Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health Study). Clin Chem 53: 273-283, 2007
19. Valkonen VP, Palva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, Laaksonen R: Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358: 2127-2128, 2001
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985
21. Anderstam B, Katzarski K, Bergstrom J: Serum levels of N, N-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 8: 1437-1442, 1997
22. Horiguchi J, Yamamoto H, Akiyama Y, Marukawa K, Hirai N, Ito K: Coronary artery calcium scoring using 16-MDCT and a retrospective ECG-gating reconstruction algorithm. AJR Am J Roentgenol 183: 103-108, 2004
23. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827-832, 1990
24. Hydar AA, Hujairi NMA, Covic AA, Pereira D, Rubens M, Goldsmith DJA: Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 19: 2307-2312, 2004
25. Sharples EJ, Pereira D, Summers S, Cunningham J, Rubens M, Goldsmith D, Yaqoob MM: Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients. Am J Kidney Dis 43: 313-319, 2004
26. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992
27. Kielstein JT, Boger RH, Bode-Boger SM, Frohlich JC, Haller H, Ritz E, Fliser D: Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 13: 170-176, 2002
28. Zoccali C, Bode-Boger SM, Mallamaci F, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bullanuova I, Fermo I, Frohlich JC, Boger RH: Plasma concentration of asymmetric dimethylarginine and mortality in patients with endstage renal disease: a prospective study. Lancet 358: 2113-2117, 2001
29. Boger RH: Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 38: 126-136, 2006
30. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Boger SM, Haller H, Ritz E: Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J Am Soc Nephrol 16: 2456-2461, 2005
31. Iribarren C, Husson G, Sydow K, Wang BY, Sidney S, Cooke JP: Asymmetric dimethylarginine and coronary artery calcification in young adults entering middle age: the CARDIA Study. Eur J Cardiovasc Prev Rehabil 14: 222-229, 2007
32. Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, Nakata S, Tsujimoto T, Toyohira Y, Hayashida Y, Sasaguri Y, Ueta Y, Nakashima Y, Yanagihara N: Asymmetric dimethylarginine produces vascular lesions in endothetial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress: Arterioscler Thromb Vasc Biol 24: 1682-1688, 2004
33. Kielstein JT, Impraim B, Simmel S, Bode-Boger SM, Tsikas D, Frolich JC, Hoeper NM, Haller H, Fliser D: Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109:172-177, 2004
34. Sydow K, Mondon CE, Schrader J, Konishi H, Cooke JP: Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol 28:692-697, 2008
35. Caglar K, Yilmaz MI, Sonme A, Cakir E, Kaya A, Acikel C, Eyileten T, Yenicesu T, Oguz Y, Bilgi C, Oktenli C, Vural A, Zoccali C: ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int 70: 781-787, 2006